111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 81103-11-9 | ||
EC NO: | |||
Molecular Formula: | C38H69NO13 | ||
Molecular Weight: | 747.9534 | ||
Specification: | |||
InChI: | InChI=1/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22?,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 | ||
Product description: Clarithromycin is a macrolide antibiotic derived from erythromycin, that present advantages over the base product, as well as providing greater added value. This product has a high bacteriostatic action in front a wide spectrum of pathogenic bacteria and is used mainly for the treatment of respiratory infections and duodenal ulcer caused by Helycobacter Pylori and infections caused by microbacteria. Ercros has a new and modern plant to manufacture this product, with high standards of quality requirement that represents a clear exponent of the reinforcement of Ercros in the pharmaceutical business. |
|||
Synonyms: | 6-O-Methylerythromycin; A-56268; Biaxin; Klacid; TE-03;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name);(3R,4S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name); | ||
Molecular Structure: |